Lilly, Merck, Pfizer-Funded Research Cites Hep B Virus In Liver Cancer
This article was originally published in PharmAsia News
Executive Summary
Singapore researchers, jointly funded by Lilly, Merck and Pfizer, said a study of 88 Hong Kong liver patients who had surgery or transplants identified the hepatitis B virus as a contributor.